Uncategorised - European Medical Journal

New Evidence Supports Finerenone Use in Heart Failure, Regardless of Frailty

Finerenone benefits heart failure patients with preserved ejection fraction, regardless of frailty, supporting its wider clinical use.

Evaluating ChatGPT’s Role in Urological Education

Students using ChatGPT alone scored lower than those attending lectures suggesting that AI tools may not sufficiently support complex learning.

Digital Inhalers Signal Impending COPD Attacks

Digital inhaler metrics may offer an early signal of impending COPD exacerbations, according to a new pilot study evaluating real-world use of the ProAir Digihaler among high-risk patients.

Global Study Reveals Wide Gaps in Paediatric Bronchiectasis Care

New global registry study reveals stark regional differences in diagnosis, treatment, and care quality for children with bronchiectasis.

New Strategies Emerge for TB-Related Drug Reactions

A personalized approach to managing tuberculosis drug reaction with eosinophilia and systemic symptoms, or TB DRESS, is gaining momentum as clinicians face increasing challenges in treating tuberculosis in immunocompromised populations, particularly people living with HIV.

Tracking A&E Demand in Sickle Cell Disease

A new cohort study analysing over 100,000 A&E visits in North Carolina has redefined what constitutes high emergency care use among people with sickle cell disease.

Cannabis Use Linked to Increased Cardiovascular Health Risks

THC, the main psychoactive compound, can stimulate the sympathetic nervous system, potentially causing tachycardia, vasoconstriction, and increased oxygen demand.

New Insight: Balance Dysfunction in Sjogren’s Syndrome

Vestibular dysfunction and impaired balance may be more common in patients with primary Sjogren’s syndrome than previously understood, according to new research exploring the condition’s neurological impact.

Improving Latent Tuberculosis Screening Prior to Immunosuppression

A new study in Calgary hospitals highlights the need to optimise latent tuberculosis testing prior to patient hospitalisation and…

Dupilumab Flagged for Higher Lymphoma Risk in Asthma

A population-based cohort study finds that asthma patients treated with dupilumab may face an increased risk of developing lymphoma, particularly T and natural killer (NK) cell subtypes, compared to those treated with standard combination inhalers.